Virtual Physiological Human

Last updated

The Virtual Physiological Human (VPH) is a European initiative that focuses on a methodological and technological framework that, once established, will enable collaborative investigation of the human body as a single complex system. [1] [2] The collective framework will make it possible to share resources and observations formed by institutions and organizations, creating disparate but integrated computer models of the mechanical, physical and biochemical functions of a living human body.

Contents

VPH is a framework which aims to be descriptive, integrative and predictive. [3] [4] [5] [6] Clapworthy et al. state that the framework should be descriptive by allowing laboratory and healthcare observations around the world "to be collected, catalogued, organized, shared and combined in any possible way." [5] It should be integrative by enabling those observations to be collaboratively analyzed by related professionals in order to create "systemic hypotheses." [5] Finally, it should be predictive by encouraging interconnections between extensible and scalable predictive models and "systemic networks that solidify those systemic hypotheses" while allowing observational comparison. [5]

The framework is formed by large collections of anatomical, physiological, and pathological data stored in digital format, typically by predictive simulations developed from these collections and by services intended to support researchers in the creation and maintenance of these models, as well as in the creation of end-user technologies to be used in the clinical practice. VPH models aim to integrate physiological processes across different length and time scales (multi-scale modelling). [3] These models make possible the combination of patient-specific data with population-based representations. The objective is to develop a systemic approach which avoids a reductionist approach and seeks not to subdivide biological systems in any particular way by dimensional scale (body, organ, tissue, cells, molecules), by scientific discipline (biology, physiology, biophysics, biochemistry, molecular biology, bioengineering) or anatomical sub-system (cardiovascular, musculoskeletal, gastrointestinal, etc.). [5]

History

The initial concepts that led to the Virtual Physiological Human initiative came from the IUPS Physiome Project. The project was started in 1997 and represented the first worldwide effort to define the physiome through the development of databases and models which facilitated the understanding of the integrative function of cells, organs, and organisms. [7] The project focused on compiling and providing a central repository of databases that would link experimental information and computational models from many laboratories into a single, self-consistent framework.

Following the launch of the Physiome Project, there were many other worldwide initiatives of loosely coupled actions all focusing on the development of methods for modelling and simulation of human pathophysiology. In 2005, an expert workshop of the Physiome was held as part of the Functional Imaging and Modelling of the Heart Conference in Barcelona where a white paper [8] entitled Towards Virtual Physiological Human: Multilevel modelling and simulation of the human anatomy and physiology was presented. The goal of this paper was to shape a clear overview of on-going relevant VPH activities, to build a consensus on how they can be complemented by new initiatives for researchers in the EU and to identify possible mid-term and long term research challenges.

In 2006, the European Commission funded a coordination and support action entitled STEP: Structuring The EuroPhysiome. The STEP consortium promoted a significant consensus process that involved more than 300 stakeholders including researchers, industry experts, policy makers, clinicians, etc. The prime result of this process was a booklet entitled Seeding the EuroPhysiome: A Roadmap to the Virtual Physiological Human. [6] The STEP action and the resulting research roadmap were instrumental in the development of the VHP concept and in the initiation of much larger process that involves significant research funding, large collaborative projects, and a number of connected initiatives, not only in Europe but also in the United States, Japan, and China.

VPH now forms a core target of the 7th Framework Programme [9] of the European Commission, and aims to support the development of patient-specific computer models and their application in personalised and predictive healthcare. [10] The Virtual Physiological Human Network of Excellence (VPH NoE) aims to connect the various VPH projects within the 7th Framework Programme.

Goals of the initiative

VPH-related projects have received substantial funding from the European Commission in order to further scientific progress in this area. The European Commission is insistent that VPH-related projects demonstrate strong industrial participation and clearly indicate a route from basic science into clinical practice. [5] In the future, it is hoped that the VPH will eventually lead to a better healthcare system which aims to produce the following benefits: [6]

Personalized care solutions are a key aim of the VPH, with new modelling environments for predictive, individualized healthcare to result in better patient safety and drug efficacy. It is anticipated that the VPH could also result in healthcare improvement through greater understanding of pathophysiological processes. [3] The use of biomedical data from a patient to simulate potential treatments and outcomes could prevent the patient from experiencing unnecessary or ineffective treatments. [11] The use of in silico (by computer simulation) modelling and testing of drugs could also reduce the need for experiments on animals.

A future goal is that there also will be a more holistic approach to medicine with the body treated as a single multi-organ system rather than as a collection of individual organs. Advanced integrative tools should further help to improve the European healthcare system on a number of different levels that include diagnosis, treatment and care of patients and in particular quality of life. [6]

Projects

ImmunoGrid

ImmunoGrid is a project funded by the EU under Framework 6, to model and simulate the human immune system using grid computing at different physiological levels. [12]

Osteoporotic Virtual Physiological Human

VPHOP(Osteoporotic Virtual Physiological Human) is a European Osteoporosis research project within the framework of the Virtual Physiological Human initiative. With current technology, osteoporotic fractures can be predicted with an accuracy of less than 70%. Better ways to prevent and diagnose osteoporotic fractures are needed.

Current fracture predictions are based on history and examination on the basis of which key factors are identified which contribute to the increased probability of an osteoporotic fracture. This approach oversimplifies the mechanisms leading to an osteoporotic fracture and fail to take into account numerous hierarchical factors which are unique to the individual. These factors range from cell-level to body-level functions. Musculoskeletal anatomy and neuromotor control define the daily loading spectrum, including paraphysiological overloading events. Fracture events occur at the organ level and are influenced by the elasticity and geometry of bone elasticity and geometry are determined by tissue morphology. Cell activity changes tissue morphology and composition over time. Constituents of the extracellular matrix are the prime determinants of tissue strength. Accuracy could be dramatically improved if a more deterministic approach was used that accounts for those factors and their variation between individuals.

The goal of the Osteoporotic Virtual Physiological Human is to improve the accuracy of these osteoporotic fracture prediction algorithms.

See also

Related Research Articles

<span class="mw-page-title-main">Simulation</span> Imitation of the operation of a real-world process or system over time

A simulation is an imitative representation of a process or system that could exist in the real world. In this broad sense, simulation can often be used interchangeably with model. Sometimes a clear distinction between the two terms is made, in which simulations require the use of models; the model represents the key characteristics or behaviors of the selected system or process, whereas the simulation represents the evolution of the model over time. Another way to distinguish between the terms is to define simulation as experimentation with the help of a model. This definition includes time-independent simulations. Often, computers are used to execute the simulation.

The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) is one of the institutes and centers that make up the National Institutes of Health, an agency of the United States Department of Health and Human Services (HHS).

<i>In silico</i> Latin phrase referring to computer simulations

In biology and other experimental sciences, an in silico experiment is one performed on a computer or via computer simulation software. The phrase is pseudo-Latin for 'in silicon', referring to silicon in computer chips. It was coined in 1987 as an allusion to the Latin phrases in vivo, in vitro, and in situ, which are commonly used in biology. The latter phrases refer, respectively, to experiments done in living organisms, outside living organisms, and where they are found in nature.

Computational science, also known as scientific computing, technical computing or scientific computation (SC), is a division of science that uses advanced computing capabilities to understand and solve complex physical problems. This includes

<span class="mw-page-title-main">Peter Coveney</span>

Peter V. Coveney is a Professor of Physical Chemistry, Honorary Professor of Computer Science, and the Director of the Centre for Computational Science (CCS) and Associate Director of the Advanced Research Computing Centre at University College London (UCL). He is also a Professor of Applied High Performance Computing at University of Amsterdam (UvA) and Professor Adjunct at the Yale School of Medicine, Yale University. He is a Fellow of the Royal Academy of Engineering and Member of Academia Europaea. Coveney is active in a broad area of interdisciplinary research including condensed matter physics and chemistry, materials science, as well as life and medical sciences in all of which high performance computing plays a major role. The citation about Coveney on his election as a FREng says: Coveney "has made outstanding contributions across a wide range of scientific and engineering fields, including physics, chemistry, chemical engineering, materials, computer science, high performance computing and biomedicine, much of it harnessing the power of supercomputing to conduct original research at unprecedented space and time scales. He has shown outstanding leadership across these fields, manifested through running multiple initiatives and multi-partner interdisciplinary grants, in the UK, Europe and the US. His achievements at national and international level in advocacy and enablement are exceptional".

The term virtual patient is used to describe interactive computer simulations used in health care education to train students on clinical processes such as making diagnoses and therapeutic decisions. Virtual patients attempt to combine modern technologies and game-based learning to facilitate education, and complement real clinical training. Using virtual patients is increasing in healthcare due to increased demands on healthcare professionals, education of healthcare trainees, and providing learners with a safe practice environment. There are many formats from which a virtual patient may be chosen, but the overarching principle is that of interactivity. Virtual patients typically have mechanisms where information is parsed out in response to the learners, simulating how patients respond to different treatments. Interactivity can be created with questions, specific decision-making tasks, text composition, etc., and is non-sequential. Most systems provide quantitative and qualitative feedback. In some cases, virtual patients are not full simulations themselves, but are mainly based on paper-based cases; as they do not allow for physical examination or an in-depth medical history of an actual patient. There are certain drawbacks as crucial clinical findings may be missed due to the lack of examining patients in person.

The physiome of an individual's or species' physiological state is the description of its functional behavior. The physiome describes the physiological dynamics of the normal intact organism and is built upon information and structure. The term comes from "physio-" (nature) and "-ome".

Pharmacometrics is a field of study of the methodology and application of models for disease and pharmacological measurement. It uses mathematical models of biology, pharmacology, disease, and physiology to describe and quantify interactions between xenobiotics and patients, including beneficial effects and adverse effects. It is normally applied to quantify drug, disease and trial information to aid efficient drug development, regulatory decisions and rational drug treatment in patients.

The European Institute for Biomedical Imaging Research (EIBIR) was established in 2006 as a non-profit, limited liability company on the initiative of the European Society of Radiology with funding of the European Commission within the Sixth Framework Programme.

The Living Human Project (LHP) is a project that begun in 2002 to develop a distributed repository of anatomo-functional data and simulation algorithms for the human musculoskeletal apparatus used to create the physiome of the human musculoskeletal system. In 2006 the BEL was merged with Biomed Town, an Internet community for those who have a professional interest in biomedical research.

An instructional simulation, also called an educational simulation, is a simulation of some type of reality but which also includes instructional elements that help a learner explore, navigate or obtain more information about that system or environment that cannot generally be acquired from mere experimentation. Instructional simulations are typically goal oriented and focus learners on specific facts, concepts, or applications of the system or environment. Today, most universities make lifelong learning possible by offering a virtual learning environment (VLE). Not only can users access learning at different times in their lives, but they can also immerse themselves in learning without physically moving to a learning facility, or interact face to face with an instructor in real time. Such VLEs vary widely in interactivity and scope. For example, there are virtual classes, virtual labs, virtual programs, virtual library, virtual training, etc. Researchers have classified VLE in 4 types:

Biosimulation is a computer-aided mathematical simulation of biological processes and systems and thus is an integral part of systems biology. Due to the complexity of biological systems simplified models are often used, which should only be as complex as necessary.

<span class="mw-page-title-main">GIMIAS</span>

GIMIAS is a workflow-oriented environment focused on biomedical image computing and simulation. The open-source framework is extensible through plug-ins and is focused on building research and clinical software prototypes. Gimias has been used to develop clinical prototypes in the fields of cardiac imaging and simulation, angiography imaging and simulation, and neurology

Medical image computing (MIC) is an interdisciplinary field at the intersection of computer science, information engineering, electrical engineering, physics, mathematics and medicine. This field develops computational and mathematical methods for solving problems pertaining to medical images and their use for biomedical research and clinical care.

The Virtual Physiological Rat (VPR) Project is an international collaboration aimed at simulating the integrated cardiovascular function of the rat and supported by the National Institute of General Medical Sciences as a National Center for Systems Biology. The project is motivated by the fact that, although there exist both a depth of knowledge of basic cardiovascular physiology and a host of physiological and genomic data from animal models of disease, there is a lack of understanding of how multiple genes and environmental factors interact to determine cardiovascular phenotype. The Virtual Physiological Rat Project is focused on developing computational tools to capture the underlying systems physiology as well as the pathophysiological perturbations associated with disease. These tools are being developed and validated based on experimental characterization of physiological function across a number of organ systems in rat strains engineered to show relevant disease phenotypes. Computer simulation is used to integrate disparate data to explain and predict function, and to translate the findings from animal models to yield new information on specific interrelated complex diseases in humans, including hypertension, kidney disease, heart failure, and metabolic syndrome.

In silico medicine is the application of in silico research to problems involving health and medicine. It is the direct use of computer simulation in the diagnosis, treatment, or prevention of a disease. More specifically, in silico medicine is characterized by modeling, simulation, and visualization of biological and medical processes in computers with the goal of simulating real biological processes in a virtual environment.

An in silico clinical trial, also known as a virtual clinical trial, is an individualized computer simulation used in the development or regulatory evaluation of a medicinal product, device, or intervention. While completely simulated clinical trials are not feasible with current technology and understanding of biology, its development would be expected to have major benefits over current in vivo clinical trials, and research on it is being pursued.

The International Union of Physiological Sciences, abbreviated IUPS, is the global umbrella organization for physiology.

A digital twin is a digital model of an intended or actual real-world physical product, system, or process that serves as the effectively indistinguishable digital counterpart of it for practical purposes, such as simulation, integration, testing, monitoring, and maintenance. The digital twin has been intended from its initial introduction to be the underlying premise for Product Lifecycle Management and exists throughout the entire lifecycle of the physical entity it represents. Since information is granular, the digital twin representation is determined by the value-based use cases it is created to implement. The digital twin can and does often exist before there is a physical entity. The use of a digital twin in the creation phase allows the intended entity's entire lifecycle to be modeled and simulated. A digital twin of an existing entity may be used in real-time and regularly synchronized with the corresponding physical system.

<span class="mw-page-title-main">Uwe Marx</span>

Uwe Marx is a German physician and biotechnologist, and one of the world’s leading researchers in the fields of organ-on-a-chip technology and antibody production.

References

  1. ↑ Clapworthy et al. 2007
  2. ↑ According to the STEP research road map Archived August 28, 2008, at the Wayback Machine
  3. 1 2 3 Fenner JW, Brook B, Clapworthy G, Coveney PV, Feipel V, Gregersen H, et al. (2008). "The EuroPhysiome, STEP and a roadmap for the virtual physiological human". Philosophical Transactions of the Royal Society A . 366 (1878): 2979–99. Bibcode:2008RSPTA.366.2979F. doi:10.1098/rsta.2008.0089. PMID   18559316. S2CID   1211981.
  4. ↑ Viceconti M, Taddei F, Van Sint Jan S, Leardini A, Cristofolini L, Stea S, et al. (2008). "Multiscale modelling of the skeleton for the prediction of the risk of fracture". Clin Biomech (Bristol, Avon). 23 (7): 845–52. doi:10.1016/j.clinbiomech.2008.01.009. PMID   18304710.
  5. 1 2 3 4 5 6 Clapworthy G, Viceconti M, Coveney PV, Kohl P (2008). "The virtual physiological human: building a framework for computational biomedicine I. Editorial". Philosophical Transactions of the Royal Society A . 366 (1878): 2975–8. doi: 10.1098/rsta.2008.0103 . PMID   18559315.
  6. 1 2 3 4 STEP research road map Archived August 28, 2008, at the Wayback Machine
  7. ↑ Hunter PJ, Borg TK (2003). "Integration from proteins to organs: the Physiome Project". Nat Rev Mol Cell Biol. 4 (3): 237–43. doi:10.1038/nrm1054. PMID   12612642. S2CID   25185270.
  8. ↑ Ayache N, Boissel JP, Brunak S, Clapworthy G, Lonsdale G, Fingberg J, Frangi A, Deco G, Hunter P, Nielsen P, Halstead M, Hose R, Magnin I, Martin-Sanchez F, Sloot P, Kaandorp J, Hoekstra A, Van Sint Jan S, Viceconti M (November 2005). "Towards virtual physiological human: Multilevel modelling and simulation of the human anatomy and physiology" (PDF). edited by DG INFSO & DG JRC.
  9. ↑ 7th Framework Programme
  10. ↑ Kohl P, Noble D (2009). "Systems biology and the virtual physiological human". Mol Syst Biol. 5 (1): 292. doi:10.1038/msb.2009.51. PMC   2724980 . PMID   19638973.
  11. ↑ Sadiq SK, Mazzeo MD, Zasada SJ, Manos S, Stoica I, Gale CV, et al. (2008). "Patient-specific simulation as a basis for clinical decision-making". Philosophical Transactions of the Royal Society A . 366 (1878): 3199–219. Bibcode:2008RSPTA.366.3199S. doi:10.1098/rsta.2008.0100. PMID   18573758. S2CID   1690327.
  12. ↑ "ImmunoGrid - The European virtual human immune system project". European Commission : CORDIS : Projects & Results Service. Retrieved 23 July 2017.

Bibliography

This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.